Buy Capnea 20mg/mlx1ml Caffeine Citrate USP

Capnea 20mg/mlx1ml contains Caffeine Citrate USP in 20mg/ml vials, used for neonatal apnea treatment. This injectable form supports respiratory function in premature infants. Ideal for hospital and clinical settings requiring precise dosing. Short-term use under medical supervision ensures safety and efficacy.

Strength

20mg/ml x 1ml

Manufacturer / TM Owner

CIPLA LTD

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Caffeine Citrate USP, the active ingredient in Capnea 20mg/mlx1ml, is primarily used to treat neonatal apnea, a condition where premature infants experience pauses in breathing. It works by stimulating the central nervous system to improve respiratory drive. This medication is also used to reduce the frequency of apneic episodes in newborns. Parents and caregivers often ask, 'what is Caffeine Citrate USP used for' in the context of neonatal care.

Side Effects

Capnea 20mg/mlx1ml helps regulate breathing patterns in premature infants by acting as a respiratory stimulant. It may increase heart rate and blood pressure slightly, which is typical for its intended use. Some infants may experience mild agitation or restlessness as the body adjusts to the medication. These effects are generally temporary and monitored by healthcare professionals.

Precautions & Warnings

Capnea 20mg/mlx1ml should only be administered under the supervision of a healthcare provider experienced in neonatal care. Regular monitoring of heart rate, blood pressure, and blood glucose levels is recommended during treatment. Ensure the vial is inspected for particles or discoloration before use. Discard any unused portion as directed by a pharmacist.

Avoid Interactions

Caffeine Citrate USP may interact with other central nervous system stimulants, potentially increasing their effects. Medications metabolized by the liver, such as certain antibiotics or anticonvulsants, could alter caffeine levels in the blood. Always inform your healthcare provider about all medications and supplements being used. Avoid concurrent use with other caffeine-containing products unless approved by a doctor.

References

Frequently Asked Questions

It is used to treat neonatal apnea, a condition involving pauses in breathing in premature infants.

It is given as an intravenous injection by a healthcare professional in a clinical setting.

Common effects may include increased heart rate or mild agitation, which are typically temporary.

No, it requires administration by trained medical staff in a hospital or clinical environment.

It is generally used for short-term treatment; long-term safety should be determined by a healthcare provider.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.